DCA Vantage Analyzer
Provide the clinical confidence your patients deserve. The DCA Vantage® Analyzer helps you monitor glycemic control and detect early kidney disease in environments ranging from the physician’s office to remote, point-of-care coordinated sites in hospitals and multisite practices. Meet lab-quality testing standards with an analyzer that speeds and simplifies diabetes tests and delivers accurate,1 clinically relevant results shown to improve decision-making,2,3 patient compliance, and outcomes.4
- Manage diabetes patients more effectively
- Improve workflow in office or clinic
- Simplify management of diabetes testing in decentralized settings
- One of just two HbA1c analyzers that meet NGSP performance criteria1
- Used by three out of four physicians who perform HbA1c testing in their office5
Vond u deze informatie nuttig?
1. Lenters-Westra E, Slingerland RJ. Clin Chem 2010;56(1):44.
2. Thaler LM, et al. Diabetes Care 1999;22:1415-21.
3. Miller CD, et al. Diabetes Care 2003;26:1158-63.
4. Cagliero E, et al. Diabetes Care 1999;22:1785-9.
5. GHX Market Intelligence, market data report. 4Q 2012 Report.
The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.